Frederick W Driscoll Flexion Therapeutics Inc (FLXN) insider trading activity

Frederick W Driscoll is Chief Financial Officer of Flexion Therapeutics Inc. Currently has a direct ownership of 0 shares of FLXN, which is worth approximately $0. The most recent transaction as insider was on Nov 19, 2021, when has been sold 30,680 shares (Common Stock) at a price of $8.5 per share, resulting in proceeds of $260,780. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

FREDERICK W DRISCOLL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 19 2021	SELL Sale (or disposition) back to the issuer	$260,780 $8.5 p/Share	30,680 Reduced 100.0%	0 Common Stock
Jun 01 2021	BUY Grant, award, or other acquisition	-	28,000 Added 47.72%	30,680 Common Stock

Also insider at

CUE

Cue Biopharma, Inc. Healthcare

MEIP

MEI Pharma, Inc. Healthcare

CLRB

Cellectar Biosciences, Inc. Healthcare

Director

RCOR

Renovacor, Inc. Healthcare

Chief Financial Officer

FWD